We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

Aker BioMarine’s sustainability efforts featured in Medium

In an article by Monica Sanders from Authority Magazine, featured in Medium.com, she discusses with Pål Skogrand, VP Policy...

First commercial agreement signed for Lysoveta

Oslo, 1 September 2022: Reference is made to the stock exchange release on 11 January 2021, with the announcement of the...

Aker BioMarine - second quarter 2022

14 July 2022: Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 73 million and Adjusted EBITDA...

Ocean 14 Capital invests in AION

Ocean 14 Capital Ltd., a private equity firm that invests in companies and technologies offering sustainable solutions for...

Aker BioMarine - first quarter 2022

29 April 2022: Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 56.9 million and Adjusted...

Aker BioMarine - results for the fourth quarter and full year 2021

Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 75.7 million and Adjusted EBITDA of USD 7.2...

Aker BioMarine appoints new EVP for Human Health & Nutrition business area

Simon Seward has been appointed EVP of Human Health & Nutrition in Aker BioMarine ASA from today. He is an industry leader...

New Study: Krill Oil Significantly Reduces Major Cardiovascular Risk Factors

A ‘game-changer’ within heart health, says researcher. Krill oil significantly reduces triglyceride levels in the blood - an...

Aker BioMarine appoints SVP Investor Relations

Aker BioMarine ASA is pleased to announce that Carl Christian Bachke has been appointed SVP Investor Relations effective...